Recruiting HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia NCT07137637 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, +20 more Locations Institute of Hematology and Blood Diseases Hospital, Tianjin, China — Tianjin, China View Trial Details
